Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 86

1.

Status of diabetes care among community pharmacy patients with diabetes: analysis of the Medical Expenditure Panel Survey.

Wang J, Thomas J, Byrd D, Nola K, Liu J.

J Am Pharm Assoc (2003). 2010 Jul-Aug;50(4):478-84. doi: 10.1331/JAPhA.2010.08173.

PMID:
20621865
[PubMed - indexed for MEDLINE]
2.

The Diabetes Ten City Challenge: interim clinical and humanistic outcomes of a multisite community pharmacy diabetes care program.

Fera T, Bluml BM, Ellis WM, Schaller CW, Garrett DG.

J Am Pharm Assoc (2003). 2008 Mar-Apr;48(2):181-90. doi: 10.1331/JAPhA.2008.07166.

PMID:
18359731
[PubMed - indexed for MEDLINE]
3.

The Asheville Project: long-term clinical and economic outcomes of a community pharmacy diabetes care program.

Cranor CW, Bunting BA, Christensen DB.

J Am Pharm Assoc (Wash). 2003 Mar-Apr;43(2):173-84.

PMID:
12688435
[PubMed - indexed for MEDLINE]
4.

The Asheville Project: short-term outcomes of a community pharmacy diabetes care program.

Cranor CW, Christensen DB.

J Am Pharm Assoc (Wash). 2003 Mar-Apr;43(2):149-59.

PMID:
12688433
[PubMed - indexed for MEDLINE]
5.

Impact of clinical pharmacist intervention on diabetes-related outcomes in a military treatment facility.

Wallgren S, Berry-Cabán CS, Bowers L.

Ann Pharmacother. 2012 Mar;46(3):353-7. doi: 10.1345/aph.1Q564. Epub 2012 Mar 6.

PMID:
22395249
[PubMed - indexed for MEDLINE]
6.

The Asheville Project: factors associated with outcomes of a community pharmacy diabetes care program.

Cranor CW, Christensen DB.

J Am Pharm Assoc (Wash). 2003 Mar-Apr;43(2):160-72.

PMID:
12688434
[PubMed - indexed for MEDLINE]
7.

Know your diabetes risk project: Student pharmacists educating adults about diabetes risk in a community pharmacy setting.

Letassy N, Dennis V, Lyons TJ, Harrison D, Burton M, Kirkpatrick A.

J Am Pharm Assoc (2003). 2010 Mar-Apr 1;50(2):188-94. doi: 10.1331/JAPhA.2010.09206.

PMID:
20199961
[PubMed - indexed for MEDLINE]
8.

Use of home telehealth monitoring with active medication therapy management by clinical pharmacists in veterans with poorly controlled type 2 diabetes mellitus.

McFarland M, Davis K, Wallace J, Wan J, Cassidy R, Morgan T, Venugopal D.

Pharmacotherapy. 2012 May;32(5):420-6. doi: 10.1002/j.1875-9114.2011.01038.x. Epub 2012 Apr 9.

PMID:
22488512
[PubMed - indexed for MEDLINE]
9.

Recall of A1C, blood pressure, and cholesterol levels among community pharmacy patients with diabetes.

Guirguis LM, Kieser MA, Chewning BA, Kanous NL.

J Am Pharm Assoc (2003). 2007 Jan-Feb;47(1):29-34.

PMID:
17338472
[PubMed - indexed for MEDLINE]
10.

Improvements in diabetes processes of care and intermediate outcomes: United States, 1988-2002.

Saaddine JB, Cadwell B, Gregg EW, Engelgau MM, Vinicor F, Imperatore G, Narayan KM.

Ann Intern Med. 2006 Apr 4;144(7):465-74.

PMID:
16585660
[PubMed - indexed for MEDLINE]
11.

Diabetes Ten City Challenge: final economic and clinical results.

Fera T, Bluml BM, Ellis WM.

J Am Pharm Assoc (2003). 2009 May-Jun;49(3):383-91. doi: 10.1331/JAPhA.2009.09015.

PMID:
19357068
[PubMed - indexed for MEDLINE]
12.

Community pharmacy Target Intervention Program to improve aspirin use in persons with diabetes.

Haggerty SA, Cerulli J, Zeolla MM, Cottrell JS, Weck MB, Faragon JJ.

J Am Pharm Assoc (2003). 2005 Jan-Feb;45(1):17-22.

PMID:
15730113
[PubMed - indexed for MEDLINE]
13.

Multiple pharmacy use and types of pharmacies used to obtain prescriptions.

Look KA, Mott DA.

J Am Pharm Assoc (2003). 2013 Nov-Dec;53(6):601-10. doi: 10.1331/JAPhA.2013.13040.

PMID:
24091483
[PubMed - indexed for MEDLINE]
14.

Evaluation of a diabetes management program using selected HEDIS measures.

Planas LG, Crosby KM, Farmer KC, Harrison DL.

J Am Pharm Assoc (2003). 2012;52(6):e130-8. doi: 10.1331/JAPhA.2012.11148.

PMID:
23224336
[PubMed - indexed for MEDLINE]
15.

A pharmacist visit improves diabetes standards in a patient-centered medical home (PCMH).

Edwards HD, Webb RD, Scheid DC, Britton ML, Armor BL.

Am J Med Qual. 2012 Nov-Dec;27(6):529-34. doi: 10.1177/1062860612444304. Epub 2012 Jun 7.

PMID:
22679128
[PubMed - indexed for MEDLINE]
16.

Influence of pharmacist intervention on prescribing of angiotensin-converting-enzyme inhibitors, angiotensin II-receptor blockers, and aspirin for diabetic patients.

LaMarr B, Valdez C, Driscoll K, Ryan M.

Am J Health Syst Pharm. 2010 Feb 15;67(4):290-4. doi: 10.2146/ajhp090009.

PMID:
20133534
[PubMed - indexed for MEDLINE]
17.

Perceptions of patients on Medicare Part D medication therapy management services.

Truong HA, Layson-Wolf C, de Bittner MR, Owen JA, Haupt S.

J Am Pharm Assoc (2003). 2009 May-Jun;49(3):392-8. doi: 10.1331/JAPhA.2009.08008.

PMID:
19443319
[PubMed - indexed for MEDLINE]
18.

Shared medical appointments based on the chronic care model: a quality improvement project to address the challenges of patients with diabetes with high cardiovascular risk.

Kirsh S, Watts S, Pascuzzi K, O'Day ME, Davidson D, Strauss G, Kern EO, Aron DC.

Qual Saf Health Care. 2007 Oct;16(5):349-53.

PMID:
17913775
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Outcomes from DiabetesCARE: a pharmacist-provided diabetes management service.

Johnson CL, Nicholas A, Divine H, Perrier DG, Blumenschein K, Steinke DT.

J Am Pharm Assoc (2003). 2008 Nov-Dec;48(6):722-30. doi: 10.1331/JAPhA.2008.07133.

PMID:
19019800
[PubMed - indexed for MEDLINE]
20.

Evaluation of community pharmacy service mix: evidence from the 2004 National Pharmacist Workforce Study.

Doucette WR, Kreling DH, Schommer JC, Gaither CA, Mott DA, Pedersen CA.

J Am Pharm Assoc (2003). 2006 May-Jun;46(3):348-55.

PMID:
16739756
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk